These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
235 related articles for article (PubMed ID: 34995983)
1. 1-, 2- and 3-AG as substrates of the endocannabinoid enzymes and endogenous ligands of the cannabinoid receptor 1. Farah SI; Hilston S; Tran N; Zvonok N; Makriyannis A Biochem Biophys Res Commun; 2022 Feb; 591():31-36. PubMed ID: 34995983 [TBL] [Abstract][Full Text] [Related]
2. Alterations in endocannabinoid tone following chemotherapy-induced peripheral neuropathy: effects of endocannabinoid deactivation inhibitors targeting fatty-acid amide hydrolase and monoacylglycerol lipase in comparison to reference analgesics following cisplatin treatment. Guindon J; Lai Y; Takacs SM; Bradshaw HB; Hohmann AG Pharmacol Res; 2013 Jan; 67(1):94-109. PubMed ID: 23127915 [TBL] [Abstract][Full Text] [Related]
4. Brain regional cannabinoid CB(1) receptor signalling and alternative enzymatic pathways for 2-arachidonoylglycerol generation in brain sections of diacylglycerol lipase deficient mice. Aaltonen N; Riera Ribas C; Lehtonen M; Savinainen JR; Laitinen JT Eur J Pharm Sci; 2014 Jan; 51():87-95. PubMed ID: 24012970 [TBL] [Abstract][Full Text] [Related]
5. Deregulation of the endocannabinoid system and therapeutic potential of ABHD6 blockade in the cuprizone model of demyelination. Manterola A; Bernal-Chico A; Cipriani R; Canedo-Antelo M; Moreno-García Á; Martín-Fontecha M; Pérez-Cerdá F; Sánchez-Gómez MV; Ortega-Gutiérrez S; Brown JM; Hsu KL; Cravatt B; Matute C; Mato S Biochem Pharmacol; 2018 Nov; 157():189-201. PubMed ID: 30075103 [TBL] [Abstract][Full Text] [Related]
6. Broad impact of deleting endogenous cannabinoid hydrolyzing enzymes and the CB1 cannabinoid receptor on the endogenous cannabinoid-related lipidome in eight regions of the mouse brain. Leishman E; Cornett B; Spork K; Straiker A; Mackie K; Bradshaw HB Pharmacol Res; 2016 Aug; 110():159-172. PubMed ID: 27109320 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of the endocannabinoid-regulating enzyme monoacylglycerol lipase elicits a CB Owens RA; Mustafa MA; Ignatowska-Jankowska BM; Damaj MI; Beardsley PM; Wiley JL; Niphakis MJ; Cravatt BF; Lichtman AH Neuropharmacology; 2017 Oct; 125():80-86. PubMed ID: 28673548 [TBL] [Abstract][Full Text] [Related]
8. The serine hydrolase ABHD6 controls the accumulation and efficacy of 2-AG at cannabinoid receptors. Marrs WR; Blankman JL; Horne EA; Thomazeau A; Lin YH; Coy J; Bodor AL; Muccioli GG; Hu SS; Woodruff G; Fung S; Lafourcade M; Alexander JP; Long JZ; Li W; Xu C; Möller T; Mackie K; Manzoni OJ; Cravatt BF; Stella N Nat Neurosci; 2010 Aug; 13(8):951-7. PubMed ID: 20657592 [TBL] [Abstract][Full Text] [Related]
9. Peripheral antinociceptive effects of inhibitors of monoacylglycerol lipase in a rat model of inflammatory pain. Guindon J; Guijarro A; Piomelli D; Hohmann AG Br J Pharmacol; 2011 Aug; 163(7):1464-78. PubMed ID: 21198549 [TBL] [Abstract][Full Text] [Related]
10. Opposite control of frontocortical 2-arachidonoylglycerol turnover rate by cannabinoid type-1 receptors located on glutamatergic neurons and on astrocytes. Belluomo I; Matias I; Pernègre C; Marsicano G; Chaouloff F J Neurochem; 2015 Apr; 133(1):26-37. PubMed ID: 25626460 [TBL] [Abstract][Full Text] [Related]
13. Discovery and development of endocannabinoid-hydrolyzing enzyme inhibitors. Minkkilä A; Saario S; Nevalainen T Curr Top Med Chem; 2010; 10(8):828-58. PubMed ID: 20370710 [TBL] [Abstract][Full Text] [Related]
14. Pharmacological inhibition of 2-arachidonoilglycerol hydrolysis enhances memory consolidation in rats through CB2 receptor activation and mTOR signaling modulation. Ratano P; Petrella C; Forti F; Passeri PP; Morena M; Palmery M; Trezza V; Severini C; Campolongo P Neuropharmacology; 2018 Aug; 138():210-218. PubMed ID: 29842858 [TBL] [Abstract][Full Text] [Related]
15. Monoglyceride lipase-like enzymatic activity is responsible for hydrolysis of 2-arachidonoylglycerol in rat cerebellar membranes. Saario SM; Savinainen JR; Laitinen JT; Järvinen T; Niemi R Biochem Pharmacol; 2004 Apr; 67(7):1381-7. PubMed ID: 15013854 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of monoacylglycerol lipase and fatty acid amide hydrolase by analogues of 2-arachidonoylglycerol. Ghafouri N; Tiger G; Razdan RK; Mahadevan A; Pertwee RG; Martin BR; Fowler CJ Br J Pharmacol; 2004 Nov; 143(6):774-84. PubMed ID: 15492019 [TBL] [Abstract][Full Text] [Related]
17. The role of CB Karwad MA; Couch DG; Theophilidou E; Sarmad S; Barrett DA; Larvin M; Wright KL; Lund JN; O'Sullivan SE FASEB J; 2017 Aug; 31(8):3267-3277. PubMed ID: 28404744 [TBL] [Abstract][Full Text] [Related]
18. Fatty acid amide hydrolase but not monoacyl glycerol lipase controls cell death induced by the endocannabinoid 2-arachidonoyl glycerol in hepatic cell populations. Siegmund SV; Wojtalla A; Schlosser M; Zimmer A; Singer MV Biochem Biophys Res Commun; 2013 Jul; 437(1):48-54. PubMed ID: 23806692 [TBL] [Abstract][Full Text] [Related]
19. Dual blockade of FAAH and MAGL identifies behavioral processes regulated by endocannabinoid crosstalk in vivo. Long JZ; Nomura DK; Vann RE; Walentiny DM; Booker L; Jin X; Burston JJ; Sim-Selley LJ; Lichtman AH; Wiley JL; Cravatt BF Proc Natl Acad Sci U S A; 2009 Dec; 106(48):20270-5. PubMed ID: 19918051 [TBL] [Abstract][Full Text] [Related]
20. Attenuation of anticipatory nausea in a rat model of contextually elicited conditioned gaping by enhancement of the endocannabinoid system. Limebeer CL; Abdullah RA; Rock EM; Imhof E; Wang K; Lichtman AH; Parker LA Psychopharmacology (Berl); 2014 Feb; 231(3):603-12. PubMed ID: 24043345 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]